Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics
Aiforia, a Helsinki-based life-science company providing deep learning AI solutions for pathology, has secured €20 million in venture debt financing from the European Investment Bank (EIB). Supported under the European Commission’s InvestEU programme, the financing will accelerate Aiforia’s product development and boost its commercial operations. The financing is divided into three tranches, with…
Helsinki-based Aiforia, a life-science company specializing in AI-powered cancer diagnostics, has secured €20 million in venture debt financing from the European Investment Bank (EIB). The financing, supported by the European Commission’s InvestEU programme, will bolster Aiforia’s product development and commercial operations. Aiforia’s CEO, Jukka Tapaninen, expressed optimism about the financing, stating that it will enable the company to accelerate product development, expand its international reach, and improve patient care through AI-powered image analysis solutions.
Brief written by urgent.news from EU-Startups's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
